Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach
- Author
- CAZAP, E. L; GISSELBRECHT, C; SMITH, F. P; ESTEVEZ, R. A; ALVAREZ, C. A; LAGARDE, C; HANNOIS, A; AHMED, S; SCHEIN, P. S; WOOLLEY, P. V
Univ. Salvador, catedra oncologia - Source
Cancer treatment reports. 1986, Vol 70, Num 6, pp 781-783 ; ref : 11 ref
- CODEN
- CTRRDO
- ISSN
- 0361-5960
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- National Institute of Health, Silver Spring, MD
/
US Department of Health, Education and Welfare, Silver Spring, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anthracyclines Anticancéreux Appareil digestif pathologie Appareil respiratoire pathologie Bronchopulmonaire Cisplatine Doxorubicine Epithélioma glandulaire Essai clinique phase II Estomac Fluorouracil Homme Platine II Complexe Polychimiothérapie Stade avancé Tumeur
- Keyword (en)
- Anthracyclins Antineoplastic agent Digestive diseases Respiratory disease Bronchopulmonary Adenocarcinoma Phase II trial Stomach Human Platinum II Complexes Polychemotherapy Advanced stage Tumor
- Keyword (es)
- Anticanceroso Aparato digestivo patologia Aparato respiratorio patologia Broncopulmonar Adenocarcinoma Ensayo clinico fase II Estomago Hombre Poliquimioterapia Estadio avanzado Tumor
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 8711540
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Cancer treatment reports\";s:9:\"\u0000*\u0000stitle\";s:17:\"Cancer treat. rep\";s:7:\"\u0000*\u0000date\";s:4:\"1986\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"781\";s:8:\"\u0000*\u0000epage\";s:3:\"783\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0361-5960\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CAZAP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"GISSELBRECHT, C\";i:1;s:11:\"SMITH, F. P\";i:2;s:13:\"ESTEVEZ, R. A\";i:3;s:13:\"ALVAREZ, C. A\";i:4;s:10:\"LAGARDE, C\";i:5;s:10:\"HANNOIS, A\";i:6;s:8:\"AHMED, S\";i:7;s:12:\"SCHEIN, P. S\";i:8;s:13:\"WOOLLEY, P. V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTRRDO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:8:\"\u0000*\u0000place\";s:17:\"Silver Spring, MD\";s:6:\"\u0000*\u0000pub\";s:28:\"National Institute of Health\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Cancer treatment reports\";s:9:\"\u0000*\u0000stitle\";s:17:\"Cancer treat. rep\";s:7:\"\u0000*\u0000date\";s:4:\"1986\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"781\";s:8:\"\u0000*\u0000epage\";s:3:\"783\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0361-5960\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CAZAP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"GISSELBRECHT, C\";i:1;s:11:\"SMITH, F. P\";i:2;s:13:\"ESTEVEZ, R. A\";i:3;s:13:\"ALVAREZ, C. A\";i:4;s:10:\"LAGARDE, C\";i:5;s:10:\"HANNOIS, A\";i:6;s:8:\"AHMED, S\";i:7;s:12:\"SCHEIN, P. S\";i:8;s:13:\"WOOLLEY, P. V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTRRDO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:8:\"\u0000*\u0000place\";s:17:\"Silver Spring, MD\";s:6:\"\u0000*\u0000pub\";s:28:\"National Institute of Health\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Cancer treatment reports\";s:9:\"\u0000*\u0000stitle\";s:17:\"Cancer treat. rep\";s:7:\"\u0000*\u0000date\";s:4:\"1986\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"781\";s:8:\"\u0000*\u0000epage\";s:3:\"783\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0361-5960\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CAZAP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"GISSELBRECHT, C\";i:1;s:11:\"SMITH, F. P\";i:2;s:13:\"ESTEVEZ, R. A\";i:3;s:13:\"ALVAREZ, C. A\";i:4;s:10:\"LAGARDE, C\";i:5;s:10:\"HANNOIS, A\";i:6;s:8:\"AHMED, S\";i:7;s:12:\"SCHEIN, P. S\";i:8;s:13:\"WOOLLEY, P. V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTRRDO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:8:\"\u0000*\u0000place\";s:17:\"Silver Spring, MD\";s:6:\"\u0000*\u0000pub\";s:28:\"National Institute of Health\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Cancer treatment reports\";s:9:\"\u0000*\u0000stitle\";s:17:\"Cancer treat. rep\";s:7:\"\u0000*\u0000date\";s:4:\"1986\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"781\";s:8:\"\u0000*\u0000epage\";s:3:\"783\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0361-5960\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CAZAP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"GISSELBRECHT, C\";i:1;s:11:\"SMITH, F. P\";i:2;s:13:\"ESTEVEZ, R. A\";i:3;s:13:\"ALVAREZ, C. A\";i:4;s:10:\"LAGARDE, C\";i:5;s:10:\"HANNOIS, A\";i:6;s:8:\"AHMED, S\";i:7;s:12:\"SCHEIN, P. S\";i:8;s:13:\"WOOLLEY, P. V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTRRDO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:8:\"\u0000*\u0000place\";s:17:\"Silver Spring, MD\";s:6:\"\u0000*\u0000pub\";s:28:\"National Institute of Health\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Cancer treatment reports\";s:9:\"\u0000*\u0000stitle\";s:17:\"Cancer treat. rep\";s:7:\"\u0000*\u0000date\";s:4:\"1986\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"781\";s:8:\"\u0000*\u0000epage\";s:3:\"783\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0361-5960\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CAZAP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. L\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:15:\"GISSELBRECHT, C\";i:1;s:11:\"SMITH, F. P\";i:2;s:13:\"ESTEVEZ, R. A\";i:3;s:13:\"ALVAREZ, C. A\";i:4;s:10:\"LAGARDE, C\";i:5;s:10:\"HANNOIS, A\";i:6;s:8:\"AHMED, S\";i:7;s:12:\"SCHEIN, P. S\";i:8;s:13:\"WOOLLEY, P. V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CTRRDO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:113:\"Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach\";s:8:\"\u0000*\u0000place\";s:17:\"Silver Spring, MD\";s:6:\"\u0000*\u0000pub\";s:28:\"National Institute of Health\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
